
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $12.7B | $14.7B | $13.4B | $12.7B | $12.9B | |
Revenue Growth (YoY) | 0.56% | 15.88% | -8.38% | -5.57% | 1.68% | |
Cost of Revenues | $10.2B | $11.9B | $11.7B | $11.1B | $11B | |
Gross Profit | $2.4B | $2.8B | $1.8B | $1.6B | $1.9B | |
Gross Profit Margin | 19.21% | 19.09% | 13.13% | 12.74% | 14.91% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8B | $2B | $1.9B | $1.9B | $1.9B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.8B | $2B | $1.9B | $2B | $1.9B | |
Operating Income | $667.3M | $768.2M | -$105.7M | -$353.3M | $72.1M | |
Net Interest Expenses | $66.7M | $62.7M | $147M | $204.5M | $166M | |
EBT. Incl. Unusual Items | $556.6M | $730.8M | -$166.7M | -$482.8M | -$80.3M | |
Earnings of Discontinued Ops. | $283.5M | -- | -- | -- | -- | |
Income Tax Expense | $121M | $184.2M | -$35.1M | $11M | $51.9M | |
Net Income to Company | $631.1M | $794.6M | -$21.4M | -$282.2M | $104.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $719.2M | $546.6M | -$131.6M | -$493.7M | -$132.2M | |
Basic EPS (Cont. Ops) | $5.00 | $3.81 | -$0.96 | -$3.66 | -$0.98 | |
Diluted EPS (Cont. Ops) | $5.00 | $3.81 | -$0.96 | -$3.66 | -$0.98 | |
Weighted Average Basic Share | $143.7M | $143.5M | $137.3M | $135M | $135M | |
Weighted Average Diluted Share | $143.9M | $144.3M | $139M | $136.3M | $136.1M | |
EBITDA | $1.1B | $1.3B | $443.4M | $304M | $727.7M | |
EBIT | $612.6M | $778.5M | -$94M | -$288.8M | $118.7M | |
Revenue (Reported) | $12.7B | $14.7B | $13.4B | $12.7B | $12.9B | |
Operating Income (Reported) | $667.3M | $768.2M | -$105.7M | -$353.3M | $72.1M | |
Operating Income (Adjusted) | $612.6M | $778.5M | -$94M | -$288.8M | $118.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $3.2B | $3.1B | $3B | $3.1B | |
Revenue Growth (YoY) | 25.43% | -6.74% | -2.86% | -4.59% | 1.94% | |
Cost of Revenues | $2.7B | $2.7B | $2.7B | $2.6B | $2.6B | |
Gross Profit | $737.4M | $557.2M | $412.2M | $381.6M | $485.4M | |
Gross Profit Margin | 21.27% | 17.24% | 13.12% | 12.74% | 15.89% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $451.4M | $467.7M | $444M | $452.3M | $458.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $463M | $388.3M | $436.8M | $450.9M | $443.1M | |
Operating Income | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Net Interest Expenses | $14.3M | $27.1M | $49.2M | $54M | $35.8M | |
EBT. Incl. Unusual Items | $260M | $142M | -$73.9M | -$123.3M | $6.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $74M | $40M | -$17.4M | -$4.8M | $2.6M | |
Net Income to Company | $274.3M | $169.1M | -$24.6M | -$69.4M | $42.4M | |
Minority Interest in Earnings | -- | $107.4K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $185.8M | $102M | -$56.4M | -$118.6M | $3.9M | |
Basic EPS (Cont. Ops) | $1.29 | $0.73 | -$0.42 | -$0.88 | $0.03 | |
Diluted EPS (Cont. Ops) | $1.29 | $0.73 | -$0.42 | -$0.88 | $0.03 | |
Weighted Average Basic Share | $143.7M | $139.8M | $135M | $135M | $135.1M | |
Weighted Average Diluted Share | $144.2M | $141M | $136.2M | $135.6M | $136.6M | |
EBITDA | $404.7M | $301.2M | $119.4M | $83.5M | $179.7M | |
EBIT | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Revenue (Reported) | $3.5B | $3.2B | $3.1B | $3B | $3.1B | |
Operating Income (Reported) | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Operating Income (Adjusted) | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $13.5B | $14.4B | $13.3B | $12.6B | $13B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $10.7B | $11.8B | $11.7B | $11B | $10.9B | |
Gross Profit | $2.8B | $2.6B | $1.6B | $1.6B | $2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8B | $2B | $1.8B | $1.9B | $1.9B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.8B | $2B | $1.9B | $1.9B | $1.8B | |
Operating Income | $960.7M | $669M | -$267.2M | -$327.6M | $212.7M | |
Net Interest Expenses | $62.7M | $75.2M | $166.9M | $205.3M | $166.8M | |
EBT. Incl. Unusual Items | $851.3M | $618.3M | -$353.3M | -$532.8M | $46.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $197.7M | $152.1M | -$85.6M | $23.2M | $58.4M | |
Net Income to Company | $892.8M | $689.3M | -$215.1M | -$327.1M | $216.1M | |
Minority Interest in Earnings | -- | $220.6K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $653.7M | $466.4M | -$267.8M | -$556.2M | -$12.3M | |
Basic EPS (Cont. Ops) | $4.55 | $3.27 | -$1.96 | -$4.12 | -$0.09 | |
Diluted EPS (Cont. Ops) | $4.54 | $3.26 | -$1.96 | -$4.12 | -$0.09 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.4B | $1.2B | $290.9M | $274.3M | $806.1M | |
EBIT | $902.4M | $679M | -$256.3M | -$327.6M | $212.7M | |
Revenue (Reported) | $13.5B | $14.4B | $13.3B | $12.6B | $13B | |
Operating Income (Reported) | $960.7M | $669M | -$267.2M | -$327.6M | $212.7M | |
Operating Income (Adjusted) | $902.4M | $679M | -$256.3M | -$327.6M | $212.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $3.2B | $3.1B | $3B | $3.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.7B | $2.7B | $2.7B | $2.6B | $2.6B | |
Gross Profit | $737.4M | $557.2M | $412.2M | $381.6M | $485.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $451.4M | $467.7M | $444M | $452.3M | $458.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $463M | $388.3M | $436.8M | $450.9M | $443.1M | |
Operating Income | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Net Interest Expenses | $14.3M | $27.1M | $49.2M | $54M | $35.8M | |
EBT. Incl. Unusual Items | $260M | $142M | -$73.9M | -$123.3M | $6.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $74M | $40M | -$17.4M | -$4.8M | $2.6M | |
Net Income to Company | $274.3M | $169.1M | -$24.6M | -$69.4M | $42.4M | |
Minority Interest in Earnings | -- | $107.4K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $185.8M | $102M | -$56.4M | -$118.6M | $3.9M | |
Basic EPS (Cont. Ops) | $1.29 | $0.73 | -$0.42 | -$0.88 | $0.03 | |
Diluted EPS (Cont. Ops) | $1.29 | $0.73 | -$0.42 | -$0.88 | $0.03 | |
Weighted Average Basic Share | $143.7M | $139.8M | $135M | $135M | $135.1M | |
Weighted Average Diluted Share | $144.2M | $141M | $136.2M | $135.6M | $136.6M | |
EBITDA | $404.7M | $301.2M | $119.4M | $83.5M | $179.7M | |
EBIT | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Revenue (Reported) | $3.5B | $3.2B | $3.1B | $3B | $3.1B | |
Operating Income (Reported) | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M | |
Operating Income (Adjusted) | $274.3M | $169M | -$24.7M | -$69.3M | $42.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.5B | $1.2B | $1.7B | $1.5B | $1.5B | |
Short Term Investments | $21M | $18.2M | $16.1M | $16.6M | $15.2M | |
Accounts Receivable, Net | $2.4B | $2.6B | $2.1B | $2.2B | $2.2B | |
Inventory | $1.6B | $2.3B | $2.3B | $2B | $1.9B | |
Prepaid Expenses | $3.2M | $5.1M | $1.9M | $397.3K | $1.5M | |
Other Current Assets | -$122.1K | -- | $95.9K | -- | $181.4K | |
Total Current Assets | $7.1B | $6.7B | $6.7B | $6.3B | $6.2B | |
Property Plant And Equipment | $2.8B | $3.1B | $3.2B | $3.3B | $3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $777.8M | $739.5M | $679.4M | $653.5M | $489.2M | |
Other Intangibles | $425M | $442.1M | $501.1M | $534.1M | $477.3M | |
Other Long-Term Assets | $122.1K | $221.1K | -$95.9K | $99.3K | -$90.7K | |
Total Assets | $12.2B | $11.9B | $12.2B | $11.9B | $11.4B | |
Accounts Payable | $3.8B | $4.2B | $3.7B | $3.6B | $3.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $95.7M | $97.5M | $101.1M | $118.3M | $119.4M | |
Other Current Liabilities | $179M | $216.3M | $146M | $104M | $113M | |
Total Current Liabilities | $6.6B | $7.6B | $6.9B | $6.8B | $6.7B | |
Long-Term Debt | $1.7B | $1.1B | $2.8B | $2.9B | $2.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.9B | $9.8B | $10.6B | $10.8B | $10.5B | |
Common Stock | $188.7M | $170.8M | $148.2M | $153.5M | $140.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2.3B | $2.1B | $1.6B | $1.1B | $881.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $854.8K | $663.2K | $671.6K | $596K | $453.6K | |
Total Equity | $2.3B | $2.1B | $1.6B | $1.1B | $882M | |
Total Liabilities and Equity | $12.2B | $11.9B | $12.2B | $11.9B | $11.4B | |
Cash and Short Terms | $2.5B | $1.2B | $1.7B | $1.5B | $1.5B | |
Total Debt | $1.9B | $1.7B | $3.6B | $3.6B | $3.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.2B | $862.4M | $1.1B | $1.3B | $1.2B | |
Short Term Investments | $18.7M | $18M | $16.2M | $15.9M | $16.5M | |
Accounts Receivable, Net | $2.4B | $2.3B | $2.2B | $2.1B | $2.1B | |
Inventory | $2B | $2.9B | $2.4B | $2B | $2.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $501.5M | $625.5M | $534.6M | $456.8M | $514.3M | |
Total Current Assets | $7.2B | $6.8B | $6.3B | $6B | $6.2B | |
Property Plant And Equipment | $2.7B | $3.2B | $3.2B | $3.2B | $3.1B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $770.1M | $757.4M | $669.4M | $618.5M | $497.4M | |
Other Intangibles | $409.6M | $466.6M | $520.2M | $523.5M | $491.8M | |
Other Long-Term Assets | $94.5M | $79.8M | $99.9M | $209.9M | $236M | |
Total Assets | $12.1B | $12.2B | $11.9B | $11.6B | $11.6B | |
Accounts Payable | $4.1B | $4.3B | $3.5B | $3.5B | $3.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $89.4M | $102.1M | $108M | $115.6M | $123.4M | |
Other Current Liabilities | $1.9B | $1.9B | $1.5B | $1.5B | $1.5B | |
Total Current Liabilities | $7.2B | $7.7B | $6.6B | $6.5B | $6.5B | |
Long-Term Debt | $1.3B | $1.5B | $2.7B | $3B | $3.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.8B | $10.3B | $10.3B | $10.5B | $10.7B | |
Common Stock | $177.2M | $167.3M | $149.2M | $145M | $154.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $803K | $757.9K | $676.1K | $469.4K | $499.6K | |
Total Equity | $2.3B | $1.9B | $1.5B | $1B | $831.6M | |
Total Liabilities and Equity | $12.1B | $12.2B | $11.9B | $11.6B | $11.6B | |
Cash and Short Terms | $2.2B | $880.4M | $1.1B | $1.3B | $1.3B | |
Total Debt | $1.8B | $2.2B | $3.6B | $3.6B | $3.8B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $631.1M | $794.6M | -$21.4M | -$282.2M | $104.3M | |
Depreciation & Amoritzation | $501M | $524.5M | $537.4M | $592.9M | $608.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$262.3M | -$263.2M | $406.2M | -$145.7M | -$268.2M | |
Change in Inventories | $135M | -$747.9M | -$155.1M | $326.7M | -$110.5M | |
Cash From Operations | $1.3B | $824.7M | -$226.7M | $378.1M | $398.1M | |
Capital Expenditures | $583.1M | $706M | $736.8M | $538.3M | $440.8M | |
Cash Acquisitions | -$873.8K | -$117.5M | -$36.6M | -- | $92.2M | |
Cash From Investing | -$558.7M | -$796.2M | -$694.1M | -$411.6M | -$405.7M | |
Dividends Paid (Ex Special Dividend) | -$219.8M | -$268.6M | -$213.2M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | $116.8K | $2.2B | $443.1M | $681.5M | |
Long-Term Debt Repaid | -$497.5M | -$33.2M | -$614M | -$247.7M | -$474.2M | |
Repurchase of Common Stock | -- | -$675.3M | -$251.4M | -- | -- | |
Other Financing Activities | $1.7M | $817.9K | -$398.8K | $188.9K | -- | |
Cash From Financing | $221M | -$1.1B | $1.6B | -$146.4M | $120.1M | |
Beginning Cash (CF) | $1.3B | $2.4B | $1.1B | $1.7B | $1.5B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.1B | -$1.1B | $634.6M | -$179.9M | $112.5M | |
Ending Cash (CF) | $2.2B | $1.3B | $1.8B | $1.4B | $1.5B | |
Levered Free Cash Flow | $720.3M | $118.7M | -$963.5M | -$160.2M | -$42.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $235M | $49M | -$11.6M | $41.2M | -- | |
Depreciation & Amoritzation | $128.6M | $129.4M | $149.2M | $146M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $71.3M | $39.6M | $76.4M | -$81.1M | -- | |
Change in Inventories | -$247.3M | -$159.8M | $65.9M | -$20.7M | -- | |
Cash From Operations | $245.3M | $150.6M | $340.9M | $136.5M | -- | |
Capital Expenditures | $153.3M | $166.8M | $119.6M | $95.5M | -- | |
Cash Acquisitions | -- | -$10.3K | -- | -- | -- | |
Cash From Investing | -$156.1M | -$146.3M | -$122.7M | -$114.7M | -- | |
Dividends Paid (Ex Special Dividend) | -$136.8M | -$130.7M | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $609.8M | $379.2K | $207.9M | -- | |
Long-Term Debt Repaid | -$16.5M | -$119.9M | -$194.2M | -$3.6M | -- | |
Repurchase of Common Stock | -- | -$49.9M | -- | -- | -- | |
Other Financing Activities | -$123.6K | -$613.2K | -- | $5.3K | -- | |
Cash From Financing | -$200.3M | $401.1M | -$137.7M | $85M | -- | |
Beginning Cash (CF) | $2.3B | $855M | $1.1B | $1.3B | -- | |
Foreign Exchange Rate Adjustment | -$5.8M | $41.1M | $18.8M | -$4.8M | -- | |
Additions / Reductions | -$111.1M | $405.4M | $80.5M | $106.7M | -- | |
Ending Cash (CF) | $2.2B | $1.2B | $1.2B | $1.4B | -- | |
Levered Free Cash Flow | $92M | -$16.1M | $221.3M | $40.9M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $892.8M | $689.3M | -$215.1M | -$327.1M | $216.1M | |
Depreciation & Amoritzation | $505.8M | $526.3M | $549.2M | $601.7M | $593.5M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$589.3M | $84.7M | $54.8M | -$34.8M | -$48.7M | |
Change in Inventories | -$244.8M | -$860.6M | $359.7M | $265.5M | -$279.8M | |
Cash From Operations | $1.6B | $314.9M | -$179M | $599.1M | $330.6M | |
Capital Expenditures | $560.6M | $752.3M | $701.5M | $525.4M | $416.6M | |
Cash Acquisitions | -$873.8K | -$117.3M | -$36.8M | -- | $92.2M | |
Cash From Investing | -$529.2M | -$854.1M | -$655.8M | -$407.9M | -$361M | |
Dividends Paid (Ex Special Dividend) | -- | -$268.6M | -$213.2M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $599.5M | -- | $1.7B | $655.8M | $707.5M | |
Long-Term Debt Repaid | -$394.8M | -$324.5M | -$361.4M | -$296.2M | -$471.6M | |
Repurchase of Common Stock | -- | -$782.7M | -- | -- | -- | |
Other Financing Activities | $1.8M | -- | -- | -- | $380.4K | |
Cash From Financing | -$430M | -$753.6M | $1.2B | $84.1M | -$48.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $601.2M | -$1.3B | $397.8M | $275.2M | -$78.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $993.7M | -$437.4M | -$880.4M | $73.6M | -$86.1M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $509.3M | $218.1M | -$36.2M | -$28.2M | $42.4M | |
Depreciation & Amoritzation | $259M | $261.6M | $293.2M | $298.8M | $137.5M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$4.4M | $311.8M | -$2.8M | -$49.3M | $251.4M | |
Change in Inventories | -$661.5M | -$686.8M | $53.8M | -$93.9M | -$242.6M | |
Cash From Operations | $271.2M | -$333.3M | -$95.3M | -$78.7M | -$282.7M | |
Capital Expenditures | $250.8M | $310.5M | $228M | $191.1M | $71.4M | |
Cash Acquisitions | -- | $204.4K | -- | -- | -- | |
Cash From Investing | -$242.5M | -$290.5M | -$228.5M | -$216.8M | -$57.5M | |
Dividends Paid (Ex Special Dividend) | -$136.8M | -$130.7M | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $1.1B | $571.1K | $420.7M | $238.9M | |
Long-Term Debt Repaid | -$25.8M | -$420.6M | -$242.2M | -$100.2M | -$93.9M | |
Repurchase of Common Stock | -- | -$157.3M | -- | -- | -- | |
Other Financing Activities | $1.1M | -$613.2K | -- | -$187.5K | $187.5K | |
Cash From Financing | -$293.7M | $697.3M | -$164.4M | $288.8M | $35.6M | |
Beginning Cash (CF) | $4.7B | $2B | $2.8B | $2.8B | $1.5B | |
Foreign Exchange Rate Adjustment | $19.5M | $55.4M | $10.9M | -$22M | -$51.9M | |
Additions / Reductions | -$264.9M | $73.6M | -$488.2M | -$6.7M | -$304.5M | |
Ending Cash (CF) | $4.4B | $2.1B | $2.3B | $2.8B | $1.2B | |
Levered Free Cash Flow | $20.5M | -$643.8M | -$323.3M | -$269.8M | -$354M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.